Kangra, India

Jagdev Singh Jaryal


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jagdev Singh Jaryal

Introduction

Jagdev Singh Jaryal is a notable inventor based in Kangra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important cancer treatment compounds. With a total of six patents to his name, Jaryal's work has had a considerable impact on the industry.

Latest Patents

Among his latest patents is a process for the preparation of dasatinib and its intermediates. This invention relates to the methods used to synthesize dasatinib, a drug used in cancer treatment. Another significant patent is for the sorafenib dimethyl sulphoxide solvate, which provides a novel pharmaceutical composition for cancer treatment. This patent also includes a new HPLC method for the identification, quantification, and isolation of related substances of sorafenib.

Career Highlights

Jagdev Singh Jaryal has worked with prominent companies in the pharmaceutical sector, including Ranbaxy Laboratories, Inc. and Sun Pharmaceutical Industries Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and synthesis.

Collaborations

Some of his notable coworkers include Swargam Sathyanarayana and Rajesh Kumar Thaper. Their collaboration has likely fostered an environment of innovation and creativity, leading to the successful development of various pharmaceutical processes.

Conclusion

Jagdev Singh Jaryal's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence cancer treatment methodologies and showcases the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…